Agape ATP (NASDAQ:ATPC – Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.33) earnings per share for the quarter, FiscalAI reports. Agape ATP had a negative net margin of 149.90% and a negative return on equity of 9.91%. The company had revenue of $0.27 million during the quarter.
Agape ATP Trading Up 1.4%
NASDAQ ATPC traded up $0.03 during trading hours on Friday, reaching $2.21. 17,324 shares of the company’s stock were exchanged, compared to its average volume of 1,488,578. The stock has a market cap of $2.21 million, a PE ratio of -0.15 and a beta of -0.92. Agape ATP has a one year low of $1.72 and a one year high of $119.00. The firm has a fifty day moving average of $2.70 and a 200-day moving average of $16.99.
Analyst Ratings Changes
ATPC has been the topic of several analyst reports. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a research note on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Agape ATP has a consensus rating of “Sell”.
Institutional Investors Weigh In On Agape ATP
A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC increased its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,130 shares of the company’s stock after acquiring an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 at the end of the most recent quarter. 0.01% of the stock is owned by hedge funds and other institutional investors.
About Agape ATP
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Featured Stories
- Five stocks we like better than Agape ATP
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
